Zuberitamab Injection
Basic Information
399
23
6
4.3(69)
Category
Subcategory & Sub-subcategory
Trade Type
Sell
Product Name
Zuberitamab Injection
Details
Manufacturer(s)
Specifications
- Formulation Type: Injectable
- Application: Anti-CD20 monoclonal antibody for CD20-positive diffuse large B-cell lymphoma (DLBCL)
- Country of Origin: China
- Regulatory Status: Approved in China for CD20-positive DLBCL
Supply Chain
Delivery:
Acceptable Lead Time: 28 days
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment